Home » Valeant Pharmaceuticals Sells Infergen to Three Rivers
Valeant Pharmaceuticals Sells Infergen to Three Rivers
Valeant Pharmaceuticals International and Three Rivers Pharmaceuticals LLC jointly announced the signing of a definitive agreement in which Valeant will divest its U.S. and Canadian rights to its hepatitis C drug, Infergen, to Three Rivers.
StreetInsider.com
StreetInsider.com
Upcoming Events
-
07May
-
14May
-
30May